Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 381 filings

Top spenders & firms Spend by issue

Clear
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $50,000.00 income
Pharmacy
View →
Q1
340B HEALTH for 340B HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy
View →
RR
PITTMAN LAW GROUP for TRULIEVE
2nd Quarter (Apr 1 - June 30) 2026 · Florida
Health Issues, Pharmacy
View →
Q1
HACKENSACK MERIDIAN HEALTH for HACKENSACK MERIDIAN HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Budget/Appropriations, Science/Technology, Health Issues, Education
View →
Q1
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q1
AEGIS LLC for TRIS PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
STUMPTOWN STRATEGIES for PRIME THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · Minnesota · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
Q1
PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · $9,000.00 income
Pharmacy
View →
Q1
E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $60,000.00 income
Pharmacy
View →
Q1
CHAMBER HILL STRATEGIES for OS THERAPIES
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate
Pharmacy, Health Issues
View →
Q1
AMERICAN COLLEGE OF CLINICAL PHARMACY for AMERICAN COLLEGE OF CLINICAL PHARMACY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues, Education
View →
RR
MR. H.R. BERT PENA for PHILLY PHARMACIES
2nd Quarter (Apr 1 - June 30) 2026 · Texas
Pharmacy
View →
Q1
DAVE KOLBE CONSULTING for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $30,000.00 income
Pharmacy
View →
Q1
HOLLAND & KNIGHT LLP for VIATRIS INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
NELSON MULLINS RILEY & SCARBOROUGH for HEMOPHILIA OF GEORGIA
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate · $20,000.00 income
Health Issues, Pharmacy, Medicare/Medicaid
View →
1T
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q1
PENN AVENUE PARTNERS for ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $80,000.00 income
Pharmacy
View →
Q1
MASON STREET CONSULTING, LLC for CAPITAL RX INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
MCDERMOTT+ LLC for ALLIANCE FOR RURAL HOSPITAL ACCESS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Pharmacy
View →
Previous Page 14 of 16 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem